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Abstract
 
Paired receptors that consist of highly related activating and inhibitory receptors are widely
involved in the regulation of the immune system. Here, we report a mouse orthologue of the
human activating paired immunoglobulin-like type 2 receptor (PILR) 
 

 
, which was cloned
from a cDNA library of natural killer (NK) cells based on its ability to associate with the
DAP12 signaling adaptor protein. The activating PILR
 

 
 was expressed not only on NK cells
but also on dendritic cells and macrophages. Furthermore, we have identified a novel CD99-
like molecule as a ligand for the activating PILR
 

 
 and inhibitory PILR
 

 
 receptors. Transcripts
of PILR ligand are present in many tissues, including some T cell lines. Cells expressing the
PILR ligand specifically activated NK cells and dendritic cells that express the activating
PILR
 

 
. Our findings reveal a new regulatory mechanism of innate immunity by PILR and its
CD99-like ligand.
Key words: natural killer cell receptor • tumor antigen • innate immunity • 
immunoglobulin superfamily • DAP12
 
Introduction
 
Activation of NK cells is controlled by both inhibitory and
activating receptors (1–4). Human and mouse NK cells ex-
press inhibitory receptors that recognize MHC class I to
avoid attack against normal cells. Inhibitory receptors possess
immunoreceptor tyrosine-based inhibitory motifs (ITIMs)
in their cytoplasmic domains and deliver inhibitory signals
via tyrosine phosphatases, such as SHP-1 (5, 6). On the
other hand, NK cells may also express activating receptors
that are highly homologous in their extracellular domains to
the inhibitory receptors. Generally, genes for these paired
inhibitory and activating NK receptors are located very
closely in the genome and likely evolved by gene duplication
(7). The activating receptors do not contain ITIM sequences
in their cytoplasmic domains, and they exhibit a positively
charged residue in transmembrane region that permits as-
sociation with immunoreceptor tyrosine-based activation
motif (ITAM)–bearing adaptor molecules, such as DAP12
(1). Unlike inhibitory receptors that recognize MHC class I,
activating receptors generally do not recognize MHC class I,
and physiological roles of most activating receptors have
remained unclear. Receptor pairs that consist of highly related
inhibitory and activating receptors are not restricted to NK
receptors. For example, families of receptors, such as leuko-
cyte Ig-like receptor (also called CD85 or Ig-like transcript),
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paired Ig-like receptor (PIR), and signal-regulatory protein,
are expressed on macrophages and DCs and consist of inhib-
itory and activating receptors (8).
Recently, we have proposed that mouse cytomegalovirus
(MCMV) has acquired the m157 gene to encode a ligand for
the inhibitory NK receptors to escape attack by NK cells (9).
On the other hand, some MCMV-resistant mouse strains ex-
press activating NK receptors for m157 (9, 10). These find-
ings suggested that NK cells may have evolved activating re-
ceptors from inhibitory receptors to control virus infection
(11). This may have been accomplished by gene conversion
in a process that used exons encoding the extracellular do-
main of an inhibitory receptor and an exon encoding the
transmembrane of another activating receptor that allows for
association with the DAP12 signaling adaptor (12). In addi-
tion, some activating human NK receptors, such as killer cell
Ig-like receptor (KIR), exhibit a potential ITIM sequence in
the 3
 

 
 untranslated region (13). From these observations, we
have proposed a new hypothesis that activating receptors
have evolved from inhibitory receptors (13). This hypothesis
may explain why activating receptors corresponding to inhib-
itory receptors exist in the immune system. ITAM-bearing
adaptor proteins, such as DAP12, FcR
 

 
, and CD3
 

 
, are used
for signal transduction by these paired activating receptors.
Therefore, identification of receptors that associate with these
adaptor molecules may be important to elucidate how NK
cells recognize specific target cells, such as virus-infected cells.
An interesting characteristic of these ITAM-bearing adap-
tor molecules is their inability to be expressed stably on the
cell surface in the absence of their partner receptor (14). By
taking advantage of this property of the adaptor molecules
and using retrovirus cDNA libraries, we have developed a
sensitive screening system for receptors that associate with
them. Using this system in the present work, we have iden-
tified a mouse orthologue of the human activating paired Ig-
like type 2 receptor (PILR) 
 

 
 (15). The PILR family con-
sists of PILR
 

 
 (also called FDF03) and PILR
 

 
 (15, 16).
Human PILR
 

 
 contains an ITIM in its cytoplasmic domain
and delivers inhibitory signals (15, 16). On the other hand,
human PILR
 

 
 does not contain an ITIM in its cytoplasmic
domain but possesses positively charged amino acids in the
transmembrane region (15). Therefore, PILR
 

 
 has been
suggested to be an activating receptor that associates with
certain ITAM-bearing adaptor molecules. However, the
physiological role, as well as ligands of PILR, have not been
identified previously. In this paper, we demonstrate that
mouse PILR recognizes a unique CD99-like protein ex-
pressed on several cell types, including T cells. Because the
PILR is expressed not only on NK cells but also on macro-
phages, DCs, and granulocytes, our findings provide a new
mechanism for the regulation of innate immunity.
 
Materials and Methods
 
Mice. 
 
C57BL/6 mice were purchased from Japan SLC.
DAP12-deficient mice backcrossed to C57BL/6 for nine genera-
tions were maintained in the University of California San Fran-
cisco animal facility (17).
 
Expression Cloning of DAP12-associated Receptors. 
 
A NH
 
2
 
-
terminal FLAG-tagged DAP12 was transfected into the 2B4 T
cell hybridoma by using the pMx-neo retrovirus vector. Thereaf-
ter, we selected a single cell clone that did not express FLAG-
DAP12 on the cell surface, but did express high levels of FLAG-
DAP12 upon transfection with the DAP12-associated Ly49D
receptor. 2 
 

 
 10
 
7
 
 FLAG-DAP12 2B4 T hybridoma cells were
infected with a retrovirus cDNA library generated from IL-2–
expanded C57BL/6 NK cells (18) at a viral titer to achieve 
 

 
30%
infection. FLAG-expressing cells were isolated by using a MACS
purification system (Miltenyi Biotech). After two rounds of en-
richment of FLAG-positive cells by MACS, almost all of cells
were stained by the anti-FLAG mAb M2 (Sigma-Aldrich) and
approximately half of them were stained by mixture of anti-
Ly49D (4E5; BD Biosciences) and Ly49H mAbs (provided by
W.M. Yokoyama, Washington University School of Medicine,
St. Louis, MO). Cells that did not express Ly49D and Ly49H
were purified by MACS. Single cell clones expressing FLAG-
DAP12, but not Ly49D or Ly49H, were obtained by limiting
dilution. The integrated cDNA was derived from the FLAG-pos-
itive cells by PCR using sense primer (5
 

 
-GGTGGACCATC-
CTCTAGACT-3
 

 
) and antisense primer (5
 

 
-TTTATTTTAT-
CGTCGATCGACC-3
 

 
), and the amplified genes were directly
sequenced.
 
Functional Analyses for Adaptor Molecules Associated PILRs.
 
NH
 
2
 
-terminal FLAG-tagged PILR
 

 
 or PILR
 

 
 were transfected
into MA5.8 T cells that lack CD3
 

 
, FcR
 

 
, and DAP12. ITAM-
bearing adapters, including CD3
 

 
, FcR
 

 
, and DAP12, were
cotransfected into the FLAG-tagged PILR transfectants by using
the pMx–internal ribosome entry site (IRES)–green fluorescent
protein (GFP) retrovirus vector. The GFP-positive cells were
sorted by using a FACSVantage™ (Becton Dickinson). The
transfectants were stimulated with immobilized anti-FLAG mAb
or control mAb. Culture supernatants were collected after 24 h,
and amounts of IL-2 were measured by ELISA.
 
Generation of PILR
 

 
-Ig and PILR
 

 
-Ig and Staining with Ig Fu-
sion Proteins. 
 
cDNA fragments corresponding to the extracellu-
lar domains of PILR
 

 
 and PILR
 

 
 were amplified by PCR using
sense primer (5
 

 
-AATCTCGAGGGAAATTCAGAAAGATC-
CAA-3
 

 
) and antisense primer (5
 

 
-AATCTCGAGTGCCAAC-
CCAACTGTGGTTT-3
 

 
), and sense primer (5
 

 
-AATCTC-
GAGGGAAATTCAGAAAGATACAACA-3
 

 
) and antisense
primer (5
 

 
-AATCTCGAGCAGGTTCATCAGTGAAGGAT-
3
 

 
), respectively. The cDNA for mouse PILR
 

 
 was inserted into
the XhoI cloning site of a modified pME18S expression vector
that contained a mouse CD150 leader segment at the 5
 

 
 termi-
nus, and the XhoI cloning site and the Fc segment of human
IgG1 at the 3
 

 
 terminus. The cDNA-encoding mouse PILR
 

 
was inserted into the XhoI cloning site of this expression vector,
except that an additional IgA tail piece sequence was inserted at
the 3
 

 
 end to generate a dodecameric Ig fusion protein (19).
COS7 cells were transiently transfected with the plasmids, and
culture supernatants were collected using standard methods. For
the staining of PILR ligand (PILR-L), cell lines were mixed with
saturating concentrations of these fusion proteins for 30 min on
ice, followed by PE-conjugated goat anti–human IgG (Jackson
ImmunoResearch Laboratories) for 30 min. Stained cells were
analyzed by using a FACSCalibur™ (Becton Dickinson).
 
Retrovirus cDNA Library Construction. 
 
A retrovirus cDNA li-
brary was constructed as reported previously (18). In brief, cDNA
was generated from mRNA purified from the EL-4 cell line us-
ing the Superscript plasmid system (Invitrogen) and was cloned
into SalI and NotI sites of the pMxs retrovirus vector (18). Li-
 Shiratori et al.
 
527
 
gated cDNA was transformed into ElectroMAX competent cells
(Invitrogen), and plasmids were purified by using a MAXI prep
plasmid purification kit (QIAGEN).
 
Cloning of PILR-L and Generation of PILR-L Transfectants. 
 
2 
 

 
10
 
7
 
 Ba/F3 cells were infected with a retrovirus cDNA library
from EL-4 at an efficiency of 
 

 
30%. 2 d after infection, cells were
stained with PILR
 

 
-Ig and PE-conjugated goat anti–human IgG,
and stained cells were purified by using a FACSVantage™. After
expansion of the purified cells, the cells were stained with PILR
 

 
-
Ig plus PE-conjugated anti–human IgG and FITC-conjugated
anti-Fc receptor mAb (2.4G2; BD Biosciences), and cells stained
with PILR
 

 
-Ig, but not 2.4G2 mAb, were obtained. Single cell
clones that were stained by PILR
 

 
-Ig were isolated by using a
Clonocyte (Becton Dickinson). Library-derived genes were am-
plified by using the PCR GC Advantage system (CLONTECH
Laboratories, Inc.) using sense primer (5
 

 
-GGTGGACCATC-
CTCTAGACT-3
 

 
) and antisense primer (5
 

 
-TTTATTTTAT-
CGTCGATCGACC-3
 

 
). Amplified cDNA was cloned into the
pMxs retrovirus vector, and nucleic acid sequences were deter-
mined. PILR-L cDNA was subcloned into the pME18S expres-
sion vector and pMx-IRES-GFP retrovirus expression vector and
transfected into 293T cells and Ba/F3 cells, respectively.
 
Surface Biotinylation and Immunoprecipitation. 
 
Biotinylated Ba/
F3 cells transfected with PILR-L were lysed with a lysis buffer
containing 1% digitonin, 50 mM Tris-HCl (pH 7.6), 150 mM
NaCl, 10 
 

 
g/ml aprotinin, 10 
 

 
g/ml leupeptin, 1 mM PMSF,
and 10 mM iodoacetamide at a concentration of 10
 
7
 
 cells/ml.
Cell lysates were immunoprecipitated with protein A preincu-
bated with PILR
 

 
-Ig, PILR
 

 
-Ig, and control Ig fusion protein,
separated on SDS-PAGE gels, and transferred onto a polyvi-
nylidene difluoride membrane (Immobilon-P; Millipore). The
biotinylated proteins were detected by using streptavidin peroxi-
dase (VECSTAIN Elite ABC kit; Vector Laboratories), the en-
hanced chemiluminescence detection system (Amersham Bio-
sciences), and LAS1000 (Fujifilm).
 
Real-time Quantitative PCR. 
 
cDNA from various tissues and
purified cell populations were prepared as described previously
(20). In brief, splenic B and T cells were stained with FITC-con-
jugated anti-B220 mAb (RA3–6B2; eBioscience) and PE-conju-
gated anti-CD3 mAb (145–2C11; BD Biosciences), respectively,
and the stained cells were purified by using a MACS. Peritoneal
macrophages and granulocytes were elicited by the i.p. injection
of 3% sodium casein, and peritoneal cells were harvested after
1 d. Peritoneal exudates were separated with 90% Percoll gradient
centrifugation (60,000 
 
g
 
, 20 min) (Amersham Pharmacia). Mac-
1
 
	
 
Gr-1
 


 
 and Mac-1
 


 
Gr-1
 
	
 
 cells were purified by using a FACS-
Vantage™
 
 
 
and were used as macrophages and granulocytes, re-
spectively. BM cells were cultured in the presence of 20 ng/ml of
mouse IL-3 for 4 wk and used as BM-derived mast cells. Splenic
NK cells and BM-derived DCs (BM-DCs) were prepared as de-
scribed in the next two paragraphs. Quantitative PCR was per-
formed by using a SYBER green PCR kit (QIAGEN) and ana-
lyzed by an iCycler (Bio-Rad Laboratories). Primers used for
amplification were as follows: 
 

 
-actin, sense primer (5
 

 
-TCTA-
CAATGAGCTGCGTGTG-3
 

 
) and antisense primer (5
 

 
-GGT-
ACGACCAGAGGCATACA-3
 

 
); PILR
 

 
, sense primer (5
 

 
-
TGGGGTTTTGGGATTGATAG-3
 

 
) and antisense primer (5
 

 
-
GCTGTTCCTGGTGAGGTCGG-3
 

 
); PILR
 

 
, sense primer
(5
 

 
-CCCAGTACTTTAGTCGAGTTAA-3
 

 
) and antisense
primer (5
 

 
-TGAAGGATTCCTCTGGTCG-3
 

 
); and PILR-L,
sense primer (5
 

 
-GGAGACTCAGGCGGCATCT-3
 

 
) and anti-
sense primer (5
 

 
-GATAGGCCACGAAGCTCGAC-3
 

 
). Tran-
scription levels of PILR
 

 
, PILR
 

 
, and PILR-L were normalized
 
to the amount of 
 

 
-actin. The relative amount of transcripts in
various organs was compared with the spleen by dividing the
transcription level of each tissue by that of spleen.
 
NK Cell Cytotoxicity Assays. 
 
NKL human NK cell lines
were transfected with pMx-IRES-GFP and pMx-IRES-GFP
containing mouse PILR
 

 
, and GFP-positive cells were collected
by using a FACSVantage™. Mouse NK cells were purified as de-
scribed previously (21). In brief, sIg
 


 
, CD4
 


 
, and CD8
 


 
 spleno-
cytes from C57BL/6 mice were stained with PE-conjugated
DX5 mAb (eBiosocience), and DX5
 
	
 
 cells were obtained by us-
ing a MACS purification system. DX5
 
	
 
 NK cells were cultured
in the presence of 1,000 U/ml IL-2 for 7 d. Cytotoxicity of NK
cells against PILR-L–transfected Ba/F3 cells and 293T cells were
analyzed by 
 
51
 
Cr release assays using standard techniques.
 
Measurement of TNF
 

 
 and NO Production. 
 
BM-DCs were
generated by culturing 5  106 BM cells with RPMI 1640 me-
dium containing 10% FCS and 200 U/ml mouse GM-CSF for
7–8 d in six-well culture plates. Nonadherent cells were collected
and cultured for 1 d. More than 95% of the cells expressed
CD11b and CD11c. 5  105 BM-DCs were cocultured with
various numbers of parental or PILR-L–transfected 293T cells in
48-well plates, as indicated in Fig. 8. After 24 h, culture superna-
tants were collected, and amounts of NO2 or TNF were mea-
sured by using the Griess reagent (Sigma-Aldrich) or a TNF
ELISA kit (Genzyme), respectively.
Results
Cloning of Mouse Activating PILR. Most activating
NK receptors associate with ITAM-bearing signal transduc-
ing adaptor molecules such as DAP12, FcR, and CD3
(21–23). Cell surface expression of these adaptor molecules
is very low in the absence of the receptors that associate
with them. To identify activating NK receptors that associ-
ate with DAP12, we generated a T cell hybridoma express-
ing a NH2-terminal FLAG-tagged DAP12 (FLAG-DAP12)
and isolated a single cell clone that lacks cell surface expres-
sion of FLAG-DAP12. We infected these cells with a retro-
virus cDNA library generated from mouse NK cells (18)
and selected and cloned cells expressing FLAG-DAP12 on
the cell surface. Using this screening system, we cloned a
mouse orthologue of the human activating PILR (15), as
well as Ly49D and Ly49H that were already known to asso-
ciate with DAP12 (24). The amino acid homology between
mouse PILR and human PILR was 38% (15). When
mouse PILR was transfected into the T cell hybridoma
expressing FLAG-DAP12, cell surface expression of FLAG-
DAP12 was induced by PILR (unpublished data). This
suggested that DAP12 associates with mouse PILR.
Human and mouse PILR (also called FDF03; references
15, 16) have been identified as an ITIM-containing inhibi-
tory receptor that is highly related to PILR. Fig. 1 demon-
strates the amino acid comparison between mouse PILR
and mouse PILR. PILR, but not PILR, contains a pos-
itively charged amino acid in the transmembrane region that
is required for association with DAP12 (25). Amino acid ho-
mology of the extracellular domain between mouse PILR
and PILR is 83%, with the NH2 terminus of the extracel-
lular domain showing very high similarity. This suggested
that PILR and PILR might recognize a common ligand.
Activation of NK Cells and Dendritic Cells by a Novel CD99-like Molecule528
Up-regulation of Cell Surface Expression of PILR by
DAP12. We analyzed the role of ITAM-bearing adap-
tor proteins, including CD3, FcR, and DAP12, on the
cell surface expression and signal transduction of mouse
PILR. NH2-terminal FLAG-tagged PILR (FLAG-
PILR) or PILR (FLAG-PILR) was transfected into a
T cell hybridoma, MA5.8, that lacks CD3, FcR, and
DAP12. As shown in Fig. 2 A, FLAG-PILR and FLAG-
PILR were expressed on the cell surface of the MA5.8
transfectants, as demonstrated by staining with an anti-
FLAG mAb. Of note, FLAG-PILR was expressed at a
higher level on MA5.8 than PILR. Next, we cotrans-
fected CD3, FcR, or DAP12 into M5.8 cells expressing
FLAG-PILR (Fig. 2 B). The expression level of FLAG-
PILR was substantially increased when DAP12, but not
CD3 or FcR, was cotransfected into the MA5.8 cells
bearing FLAG-PILR. In contrast, DAP10 did not sub-
stantially up-regulate the expression of FLAG-PILR (un-
published data). This suggests that DAP12 associates with
PILR and stabilizes the cell surface expression of PILR.
Next, we stimulated FLAG-PILR–transfected MA5.8
cells and FLAG-PILR and DAP12 cotransfected MA5.8
cells with immobilized anti-FLAG mAb (Fig. 2 C).
MA5.8 cells expressing FLAG-PILR plus DAP12 were
activated to produce IL-2 upon crosslinking of FLAG-
PILR; however, IL-2 was not induced in cells transfected
with FLAG-PILR alone, FLAG-PILR plus CD3, or
FLAG-PILR plus FcR. Together with the results that
PILR was originally cloned as a molecule that induces
cell surface expression of FLAG-DAP12, DAP12 associates
with PILR and is required for high levels of cell surface
expression and signal transduction of PILR.
Tissue Distribution of PILR and PILR Transcripts.
We analyzed the expression of PILR and PILR tran-
scripts by real-time quantitative PCR. Expressions of
PILR and PILR were relatively high in lung, liver, and
spleen (Fig. 3 A). There was no significant difference in the
tissue distribution between PILR and PILR when ana-
lyzing their expression in total organs. We analyzed the ex-
pression of PILR in various purified populations (Fig. 3
Figure 1. Amino acid comparison between mouse
PILR and PILR. Amino acid alignment of mouse
PILR and PILR is shown. Signal sequence and
transmembrane region are indicated by double and
single underline, respectively. A charged residue (K,
bold and italicized) in transmembrane domain of
PILR and the ITIM sequence in the cytoplasmic
domain of PILR are indicated (bold letters). Identical
amino acids between PILR and PILR are indicated
by asterisks. GenBank/EMBL/DDBJ accession nos. of
mouse PILR and PILR are NM_153510 and
AB122024/NM_133209, respectively.
Figure 2. (A) Role of DAP12 in the cell surface expression and signal
transduction of PILR, FLAG-PILR (solid line), and FLAG-PILR
(dashed line) was transfected into the MA5.8 cell line. Parental MA5.8
(dotted line) and the transfectants were stained with anti-FLAG mAb. Mean
fluorescence intensities of anti-FLAG mAb staining for parental MA5.8,
FLAG-PILR, and FLAG-PILR–transfected cells were 2.93, 27.0, and
369.1, respectively. (B) DAP12, CD3, or FcR were transfected into
MA5.8-expressing FLAG-PILR using the pMx-IRES-GFP retrovirus
vector. Transfectants were stained with anti-FLAG mAb and expression of
FLAG on GFP-expressing cells is shown (solid line). FLAG expression on a
mock transfectant was overlaid in this figure (dotted line). Mean fluorescence
intensities of anti-FLAG mAb staining for FLAG-PILR–expressing cells
transfected with DAP12, CD3, and FcR were 1137.7, 56.4, and 33.9,
respectively. (C) IL-2 production by MA5.8 cells and MA5.8 transfected
with FLAG-PILR and DAP12, CD3, or FcR and cultured for 1 d in the
presence of immobilized anti-FLAG mAb (shaded bar) or control mAb
(unshaded bar). IL-2 in the culture supernatants was measured by ELISA.
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B). Transcripts of PILR were detected not only in NK
cells but also in BM-DCs, peritoneal macrophages, and
granulocytes. Because DAP12 that is required for signaling
of PILR is widely distributed not only in NK cells but
also in cells of the myeloid lineage, including macrophages,
granulocytes, and DCs, PILR may play a role in the ac-
tivation of these populations. On the other hand, mac-
rophages and granulocytes also expressed the inhibitory
PILR. In contrast, NK cells and BM-DCs expressed a
very low amount of PILR transcripts. Therefore, the ex-
pression pattern of PILR and PILR seems to vary de-
pending on cell types and their activation status.
Molecular Cloning of the Ligand for PILR. To identify
the ligand for these receptors, we generated Ig fusion pro-
teins containing the extracellular domains of PILR and
PILR. When various transformed cell lines were stained
with the PILR-Ig and PILR-Ig fusion proteins, we found
that some T cell lines, such as EL-4 and 2B4, were stained
with both PILR-Ig and PILR-Ig (Fig. 4). These Ig fusion
proteins did not stain other cell lines, such as B cell and mac-
rophage lines. Because both EL-4 and 2B4 are IL-4–produc-
ing T cell lines, this suggested that expression of the ligand
for PILR might correlate with Th2 differentiation.
To elucidate the function of PILR, we sought to iden-
tify the ligand by expression cloning. Because EL-4 was
stained well by PILR-Ig (Fig. 4 A), we constructed a ret-
rovirus cDNA library from EL-4 and undertook expression
cloning using PILR-Ig. The EL-4 retrovirus cDNA li-
brary was transfected into Ba/F3 cells, which did not stain
with the PILR-Ig or PILR-Ig, and Ba/F3 cells express-
ing the ligand for PILR were purified by using a fluores-
cence-activated cell sorter. Single cell clones that were
stained with PILR-Ig were obtained and genes derived
from the cDNA library were amplified by PCR using
primers corresponding to the flanking retrovirus long ter-
minal repeat and sequenced. Fig. 5 A shows the nucleic
acid and predicted amino acid sequence of a PILR-L.
PILR-L is a type I membrane protein with a signal se-
quence, a small extracellular domain, a transmembrane re-
gion, and a short 17–amino acid cytoplasmic domain with
no evident signaling motifs. The sequence of PILR-L was
remarkable in two aspects. Surprisingly, the GC content of
PILR-L is 75%; GC-rich transcripts are rare in mammalian
cells. In addition, the short extracellular domain of PILR-L
contained no sites for N- or O-linked glycosylation, again
unusual for proteins expressed on the cell surface. PILR-L
showed 45% similarity to human CD99, 36% to human
CD99L2, and 32% to mouse CD99L2 (26). This indicates
that PILR-L belongs to CD99 family.
When the PILR-L was transfected into Ba/F3 cells
or 293T cells, the transfectants were stained well with
PILR-Ig (Fig. 5 B). Furthermore, these PILR-L transfec-
tants were also stained with PILR-Ig. This indicated that
PILR-L is a ligand for both PILR and PILR. Indeed,
when PILR-L was precipitated from cell lysates of PILR-
L–transfected Ba/F3 cells using PILR-Ig and PILR-Ig,
PILR-L was clearly detected as a 17-kD molecule, al-
though PILR-Ig precipitated much less PILR-L. A con-
trol Ig did not precipitate the 17-kD protein, and this pro-
tein was not immunoprecipitated from untransfected Ba/
F3 cells (Fig. 5 C). The actual molecular weight was the
same as the predicted molecular weight of PILR-L based
Figure 3. Transcription of PILR and PILR in
various tissues and purified populations. Transcription
of PILR and PILR in various tissues (A) and purified
populations (B) was analyzed by real-time quantitative
RT-PCR. Transcription of -actin was used as a stan-
dard, and relative expression levels of PILR and
PILR compared with amounts in the spleen are
shown. BM-DC, bone marrow–derived dendritic cells.
S. intestine, small intestine.
Figure 4. Expression of PILR-L. The cell lines indicated were stained
with PILR-Ig (solid line), PILR-Ig (dashed line), or control Ig (dotted
line), followed by PE-conjugated goat anti–human IgG. Fluorescence
intensities of PE-stained cells are shown.
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on the deduced amino acid sequence. We analyzed the ex-
pression of PILR-L transcripts by real-time quantitative
PCR. PILR-L transcripts were present in most tissues, and
expressions of PILR-L were relatively high in lung, spleen,
thymus, liver, and spinal cord (Fig. 6).
Cytotoxicity by NK Cells against PILR-L–expressing
Cells. To examine the function of mouse PILR and
PILR-L, we transfected mouse PILR into NKL, a human
NK cell line, and analyzed cytotoxicity of PILR-trans-
fected NKL cells against mouse PILR-L–transfected 293T
cells. As shown in Fig. 7 A, mouse PILR-transfected NKL
cells showed cytotoxicity against PILR-L–transfected 293T,
but not against parental 293T cells. Mock-transfected NKL
did not show cytotoxicity against PILR-L–transfected or pa-
rental 293T cells, indicating that NKL cells do not express
endogenous activating receptors that can recognize the
mouse PILR-L. In addition, soluble recombinant human
PILR-Ig did not bind to cells expressing mouse PILR-L
(unpublished data). These data indicate that mouse PILR
recognizes PILR-L–expressing cells and transduces an acti-
vating signal into NK cells. We observed that purified
mouse PILR-Ig and PILR-Ig did not block cytotoxicity
mediated by mouse PILR-expressing NKL cells against
PILR-L transfectants, probably due to insufficient affinity of
these fusion proteins (unpublished data).
Next, we analyzed cytotoxicity of IL-2–expanded mouse
NK cells against mouse PILR-L transfectants. Because
mouse Ba/F3 pro–B cells are resistant to cytotoxicity medi-
ated by mouse NK cells and do not express PILR-L, we
transfected PILR-L into Ba/F3 and used these cells as tar-
gets. When cytotoxicity of C57BL/6 NK cells against
the mouse PILR-L transfectants was analyzed, NK cells
showed significant cytotoxicity against PILR-L transfec-
tants compared with the parental Ba/F3 cells (Fig. 7 B).
We analyzed NK cells from DAP12-deficient mice (17)
because DAP12 is required for signal transduction by
PILR (Fig. 2). As predicted, NK cells from DAP12-defi-
cient mice showed almost the same cytotoxicity against
PILR-L–transfected Ba/F3 cells and parental Ba/F3 cells.
These data indicate that the DAP12-associated PILR is
involved in target cell recognition by NK cells.
Activation of DCs by PILR-L–expressing Cells. As
shown in Fig. 3, BM-DCs, as well as NK cells, express the
activating PILR but express relatively very low amounts
of inhibitory PILR transcripts compared with macro-
Figure 5. Molecular cloning of
mouse PILR-L. (A) Nucleic and
predicted amino acid sequences of
mouse PILR-L are shown. The
signal sequence and transmem-
brane domain are indicated by
double and single underline,
respectively. Sequence data of
PILR-L are available from Gen-
Bank/EMBL/DDBJ under acces-
sion no. AB122023. (B) Ba/F3
and 293T cells were transfected
with mouse PILR-L. Parental
cells and the PILR-L transfectants
were stained with PILR-Ig
(solid line), PILR-Ig (dashed
line), or control Ig (dotted line),
followed by PE-conjugated goat
anti–human IgG. (C) SDS-PAGE
analysis of PILR-L. PILR-L
transfected (	) and parental (
)
Ba/F3 cells were surface biotin-
ylated, and cell lysates were pre-
cipitated with PILR-Ig, PILR-
Ig, or control Ig fusion protein
as indicated. Precipitates were
electrophoresed by SDS-PAGE
and biotinylated proteins were
detected by using horseradish
peroxidase–conjugated streptavi-
din and the enhanced chemilumi-
nescence detection reagent.
Figure 6. Transcription of PILR-L in various tissues. Transcription of
PILR and PILR in various tissues was analyzed by real-time quantitative
RT-PCR. Transcription of -actin was used as a standard and relative
expression levels of PILR-L to the amounts present in spleen are shown.
S. intestine, small intestine.
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phages and granulocytes. This suggested that PILR-L–
expressing cells might activate not only NK cells but also
DCs. Therefore, we analyzed the function of PILR on
BM-DCs. Because DCs are known to produce nitric oxide
and TNF upon activation (27), we analyzed production
of nitric oxide and TNF production by DCs after cocul-
ture with PILR-L–expressing cells. When BM-DCs were
stimulated with PILR-L transfectants, DCs produced sig-
nificant amounts of nitric oxide and TNF (Fig. 8). In
contrast, DCs did not produce nitric oxide and TNF-
when they were cocultured with parental 293T cells lack-
ing PILR-L. These data indicate that PILR is also in-
volved in the activation of DCs.
Discussion
In the present work, we have described a mouse ortho-
logue of human activating PILR. Furthermore, we iden-
tified its ligand by using PILR-Ig fusion protein. Ex-
pression of PILR was significantly up-regulated in the
presence of DAP12, and PILR-expressing cells were acti-
vated only in the presence of DAP12. NK cells showed
significant cytotoxicity against PILR-L–expressing cells,
whereas NK cells from mice genetically lacking DAP12 did
not. These results indicate that DAP12 mediates signal
transduction for PILR.
Transcription of PILR was observed not only in NK
cells but also in macrophages, DCs, and granulocytes. Be-
cause DAP12 is widely expressed in these populations,
PILR may play an important role in the activation of var-
ious cell populations. DCs showed significant production
of nitric oxide and TNF- when they were cocultured
with PILR-L–expressing cells, indicating that PILR di-
rectly recognizes PILR-L–expressing cells and delivers acti-
vation signals in various cell types. Of note, DAP12-defi-
cient mice have been previously shown to have a defect in
APC function (17, 28), manifested by the accumulation of
DCs in the skin, an impaired delayed-type hypersensitivity
response and resistance to the induction of myelin oli-
godendrocyte glycoprotein peptide–induced experimental
autoimmune encephalomyelitis. Considering the finding
that PILR-L is expressed on T cell lines, there is the possi-
bility that interactions between PILR and PILR-L are in-
volved in some of the disorders observed in the DAP12-
deficient mice.
It is interesting that both the inhibitory PILR and the
activating PILR recognize the same ligand. Earlier analyses
have indicated that human PILR can inhibit ITAM-medi-
ated activation signals (15, 16). However, activation of NK
cells and DCs by coculture with PILR-L–bearing cells indi-
cates either a subset of NK cells or DCs bear only the acti-
vating receptor or that the activating receptor is dominant in
cells that coexpress both PILR and PILR. Indeed, tran-
scription levels of inhibitory PILR in NK cells and DCs
were very low compared with macrophages and granulo-
cytes (Fig. 3 B). Specific mAbs that distinguish PILR and
PILR are needed to define the precise distribution of these
receptors and to study their function in immune responses.
KIR, Ly49, NKG2/CD94, and NKR-P1 are paired re-
ceptors expressed by NK cells (8, 11). Similarly, myeloid
and B cells have been shown to express the paired recep-
tors, signal-regulatory protein, CD85 (also called Ig-like
transcript and leukocyte Ig-like receptor), and paired Ig-
like receptor (8, 11). PILR and PILR represent another
Figure 7. Cytotoxicity of NK cells against PILR-L–expressing cells.
(A) Cytotoxicity of mouse PILR-transfected human NKL (left) or
mock-transfected NKL cells (right) against mouse PILR-L–transfected
293T cells (closed circles) or parental 293T cells (open circles) is shown.
(B) Cytotoxicity of IL-2 expanded NK cells from wild-type mice (left) or
DAP12-deficient mice (right) against PILR-L–transfected Ba/F3 cells
(closed circles) or parental Ba/F3 cells (open circles) is shown.
Figure 8. Activation of DCs by PILR-L–expressing cells. 5  105 BM-
derived DCs were cocultured with PILR-L–transfected 293T cells (closed
circles) or parental 293T cells (open circles) at the indicated cell number
for 1 d. BM-derived DCs were also stimulated with 1 g/ml LPS as a
positive control. Nitric oxide and mouse TNF- produced in the culture
supernatants were measured. Amounts of nitric oxide and TNF- pro-
duced by DCs cultured in medium only were 1.5  0.1 M and 48.5 
7.7 pg/ml, respectively, and those produced by DCs upon LPS stimulation
were 59.1  2.8 M and 2048  127.9 pg/ml, respectively.
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example of related genes, conserved in mice and humans,
that encode activating and inhibitory receptors. Mouse
PILR and PILR are localized on chromosome 5, and
human PILR and  are localized on chromosome 7
(based on information derived from the National Center
for Biotechnology Information Genome BLAST website).
PILR and PILR are located very closely on the ge-
nome, similar to other paired receptors. Although the
amino acid homology between the extracellular domains of
the paired activating and inhibitory receptors are often very
high, often the activating receptor either fails to bind the
ligand of the inhibitory receptor or do so with much re-
duced affinity. This is the case with KIR and Ly49 recep-
tors for MHC class I (29, 30). Similarly, certain inhibitory
CD85 receptors bind MHC class I, whereas the activating
CD85 receptors do not (31, 32). Further studies are re-
quired to determine the precise affinity of mouse PILR
and PILR for PILR-L; however, we suspect that PILR
will likely be lower than PILR.
PILR-L exhibits 40% homology to human CD99. Al-
though human CD99 is present on the pairing region of
the human X and Y chromosomes, as yet the genomic lo-
calization of PILR-L has not been identified. Although it is
premature to conclude that PILR-L is a mouse orthologue
of CD99, there is a possibility that PILR-L is a mouse
orthologue for human CD99. Human CD99 is widely ex-
pressed on most hematopoietic cells (34). Similarly, we de-
tected mouse PILR-L transcripts in most tissues, suggesting
a broad distribution (Fig. 6). In addition, human CD99 has
been reported to be involved in apoptosis of T cells (33)
and migration of monocytes through epithelial cells (34) by
as yet undefined mechanisms. Expression of mouse PILR-L
on the EL-4 and 2B4 T cell lines suggests a potential role in
the regulation of T cell immune responses. In studies cur-
rently in progress, we have observed that naive CD4	 T
cells do not express PILR-L, but interestingly, when naive
CD4	 T cells were stimulated with Ag plus APC, PILR-L
was expressed on activated CD4	 T cells (unpublished
data). This finding, together with expression of PILR on
DCs (Fig. 3 B), suggests the possibility of a new pathway to
regulate T cell–APC interactions and influence helper T
cell differentiation.
What is the rationale for the evolution of paired immune
receptors with activating and inhibitory function? We have
proposed the hypothesis that pathogens may exploit inhibi-
tory receptors by acquiring ligands that can dampen im-
mune responses, but that the host may convert the inhibi-
tory immune receptors to activating immune receptors by
gene conversion due to selective pressure imposed by the
pathogen. An example is provided by the paired inhibitory
and activating Ly49 receptors on mouse NK cells that rec-
ognize a viral glycoprotein encoded by MCMV (9). Ac-
cording to this hypothesis, there is a possibility that the
paired PILRs may recognize certain molecules derived
from a pathogen. It is interesting to note that amino acid
sequence of PILR-L demonstrates 20% homology with the
PE–Pro-Glu polymorphic GC-rich repetitive sequence of
Mycobacterium tuberculosis (35). Although further studies
are necessary to reveal the biological role of PILR and
PILR-L, our present findings provide evidence for a new
receptor–ligand system involved in both the innate and
adaptive immune responses.
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